Editor's choice

Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
Mary K Crow

Annals of the Rheumatic Diseases Aug 2023, 82 (8) 999-1014; DOI: 10.1136/ard-2022-223741
Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose
Catherine L Hill, Lynette M March, Dawn Aitken, Susan E Lester, Ruth Battersby, Kristen Hynes, Tanya Fedorova, Susanna M Proudman, Michael James, Leslie G Cleland, Graeme Jones

Annals of the Rheumatic Diseases Jan 2016, 75 (1) 23-29; DOI: 10.1136/annrheumdis-2014-207169
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
D A Isenberg, M Petri, K Kalunian, Y Tanaka, M B Urowitz, R W Hoffman, M Morgan-Cox, N Iikuni, M Silk, D J Wallace

Annals of the Rheumatic Diseases Feb 2016, 75 (2) 323-331; DOI: 10.1136/annrheumdis-2015-207653
Incidence and time trends of joint surgery in patients with psoriatic arthritis: a register-based time series and cohort study from Denmark
Jørgen Guldberg-Møller, Rene Lindholm Cordtz, Lars Erik Kristensen, Lene Dreyer

Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1517-1523; DOI: 10.1136/annrheumdis-2019-215313
Genome-wide association study identifies genetic variants which predict the response of bone mineral density to teriparatide therapy
Nerea Alonso, Omar M E Albagha, Asim Azfer, Beatriz Larraz-Prieto, Kathryn Berg, Philip L Riches, Barbara Ostanek, Tomaz Kocjan, Janja Marc, Bente L Langdahl, Stuart H Ralston

Annals of the Rheumatic Diseases Jul 2023, 82 (7) 985-991; DOI: 10.1136/ard-2022-223618
Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study
Anna Karin Hedström, Lars Klareskog, Lars Alfredsson

Annals of the Rheumatic Diseases Jul 2018, 77 (7) 970-972; DOI: 10.1136/annrheumdis-2018-212973
Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
Joachim Sieper, Désirée van der Heijde, Maxime Dougados, Philip J Mease, Walter P Maksymowych, Matthew A Brown, Vipin Arora, Aileen L Pangan

Annals of the Rheumatic Diseases Jun 2013, 72 (6) 815-822; DOI: 10.1136/annrheumdis-2012-201766
Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial
In-Ho Song, Anja Weiß, Kay-Geert A Hermann, Hildrun Haibel, Christian E Althoff, Denis Poddubnyy, Joachim Listing, Ekkehard Lange, Bruce Freundlich, Martin Rudwaleit, Joachim Sieper

Annals of the Rheumatic Diseases Jun 2013, 72 (6) 823-825; DOI: 10.1136/annrheumdis-2012-202389
Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs
Alexandru-Emil Matei, Chih-Wei Chen, Lisa Kiesewetter, Andrea-Hermina Györfi, Yi-Nan Li, Thuong Trinh-Minh, Xiaohan Xu, Cuong Tran Manh, Toin van Kuppevelt, Jan Hansmann, Astrid Jüngel, Georg Schett, Florian Groeber-Becker, Jörg H W Distler

Annals of the Rheumatic Diseases Dec 2019, 78 (12) 1686-1692; DOI: 10.1136/annrheumdis-2019-216108
Does cartilage loss cause pain in osteoarthritis and if so, how much?
Kathryn Bacon, Michael P LaValley, S Reza Jafarzadeh, David Felson

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 1105-1110; DOI: 10.1136/annrheumdis-2020-217363

Main menu

Editor's choice

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Editor's choice

Pages